← Back
ORSANMICHELE
December, 08th | 10:33 - 10:36
Two-years real-life experience of a tertiary center with intravitreal brolucizumab switch for treatment of exudative neovascular age-related macular degeneration
BERETTA FEDERICO
Full program Add to calendar
Two-years real-life experience of a tertiary center with intravitreal brolucizumab switch for treatment of exudative neovascular age-related macular degeneration
BERETTA FEDERICO
Full program Add to calendar
